Future explorations may focus on enhancing Semaglutides formulation and delivery, tailoring therapy to individual patient profiles, and harnessing digital health solutions to optimize diabetes management practices
While GLP-1 therapy can reduce symptoms for some people, it might not be the right option for others, and its your healthcare providers job to help you find a treatment that suits you
In 2023, the American Society of Anesthesiologists issued more specific recommendations: discontinuation 1 day prior to surgery for patients using daily formulations, and 1 week prior for weekly formulations
Fuxe K, Borroto-Escuela DO
Of course, there's still work to be done yet: a phase 3 clinical trial is on the way, which will involve a much bigger group of participants over a longer time period